Crossmark

Prognosis in Thin Melanoma Patients: Is Slightly Less Than Excellent Still Okay?

Published Online: 2021-09-15

Published Print: 2021-11

Authors

Egger, Michael E.
License Information

Text and Data Mining valid from 2021-09-15

Version of Record valid from 2021-09-15
More Information

Article History

Received: 19 August 2021

Accepted: 22 August 2021

First Online: 15 September 2021

Conflict of interest

: The author reports research support from SkylineDX and a consultancy agreement with Iovance Biotherapeutics.

Document is current